These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15911356)

  • 1. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
    Onyango IG; Tuttle JB; Bennett JP
    Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids.
    Onyango IG; Bennett JP; Tuttle JB
    Neurobiol Dis; 2005; 19(1-2):312-22. PubMed ID: 15837587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways.
    Zhang H; Liu Y; Lao M; Ma Z; Yi X
    Exp Gerontol; 2011 Jan; 46(1):30-7. PubMed ID: 20933077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.
    Khan SM; Cassarino DS; Abramova NN; Keeney PM; Borland MK; Trimmer PA; Krebs CT; Bennett JC; Parks JK; Swerdlow RH; Parker WD; Bennett JP
    Ann Neurol; 2000 Aug; 48(2):148-55. PubMed ID: 10939564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
    Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
    J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids.
    Onyango IG; Tuttle JB; Bennett JP
    Mol Cell Neurosci; 2005 Mar; 28(3):452-61. PubMed ID: 15737736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease.
    Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y
    Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
    Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
    J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
    FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
    Kojro E; Postina R
    J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T; Perez-Polo JR; Schliebs R
    J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death.
    Onyango IG; Tuttle JB; Bennett JP
    Neurobiol Dis; 2005 Oct; 20(1):141-54. PubMed ID: 16137575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
    Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF
    Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria?
    Teng FY; Tang BL
    Biochem Biophys Res Commun; 2005 Mar; 328(1):1-5. PubMed ID: 15670741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.